Draft Genome Sequences of Two Extensively Drug-Resistant Strains of Acinetobacter baumannii Isolated from Clinical

Sara Lomonaco1, Matthew A Crawford2, Christine Lascols3,4

  • 1Division of Microbiology, Office of Regulatory Science, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA sara.lomonaco@fda.hhs.gov.

Insights

This study presents genome data for extensively drug-resistant Acinetobacter baumannii strains from Pakistan. Understanding these resistant bacteria is crucial for combating healthcare-associated infections in vulnerable patients.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Extensively drug-resistant (XDR) Acinetobacter baumannii infections are a growing global health concern.
  • Carbapenem-resistant Acinetobacter baumannii is a significant cause of healthcare-associated infections, particularly in immunocompromised individuals.

Purpose of the Study:

  • To provide draft genome assemblies for two clinical isolates of XDR Acinetobacter baumannii.
  • To contribute genomic data for understanding the epidemiology and evolution of drug-resistant Acinetobacter baumannii.

Main Methods:

  • Whole-genome sequencing of two clinical XDR Acinetobacter baumannii isolates.
  • Bioinformatic analysis to generate draft genome assemblies.

Main Results:

  • Successfully generated draft genome assemblies for two XDR Acinetobacter baumannii isolates.
  • The isolates were obtained from hospitalized patients in Pakistan.

Conclusions:

  • The genomic data will aid in further research on XDR Acinetobacter baumannii.
  • This information is vital for developing strategies to control infections caused by these resistant pathogens.